Company intelligence / Profile preview
Nastech Pharmaceutical Company Inc.
Bothell, Washington, United Statesnastech.com ↗
- Ownership
- Private
- Employees
- ~80
- Development stage
- Other
01
Overview
Nastech had multiple products in Phase 2 clinical testing, including PYY for obesity and insulin for type 2 diabetes. The company also had positive results from clinical trials for intranasal morphine gluconate for pain management and teriparatide nasal spray for osteoporosis.
- Therapeutic areas
- PulmonologyMen's HealthEndocrinologyImmunologyOncologyNeurologyInfectious Diseases
- Modalities
- Intranasal drug deliveryRNA interference (RNAi)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
PharmaciaProcter & Gamble Pharmaceuticals
Beyond the preview
Go deeper on Nastech Pharmaceutical Company Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nastech Pharmaceutical Company Inc..